XML 37 R30.htm IDEA: XBRL DOCUMENT v3.20.4
INVESTMENTS (Details)
₩ in Thousands, $ in Thousands
1 Months Ended 6 Months Ended 12 Months Ended
Dec. 31, 2019
USD ($)
Jun. 30, 2020
USD ($)
shares
Jun. 30, 2020
KRW (₩)
shares
Jun. 30, 2019
USD ($)
Jun. 30, 2019
KRW (₩)
Dec. 31, 2019
USD ($)
Jun. 30, 2020
KRW (₩)
Dec. 31, 2019
KRW (₩)
Apr. 30, 2018
Investments in and Advances to Affiliates [Line Items]                  
Investments $ 2,130 $ 2,128       $ 2,130      
Maturity term of guaranty           3 years      
Freezone I-SEC Korea Inc. [Member]                  
Investments in and Advances to Affiliates [Line Items]                  
Investments $ 330 303       $ 330      
Profit (loss) from investment   (14)   $ 45          
Freezone I-SEC Korea Inc. [Member] | Korea (South), Won                  
Investments in and Advances to Affiliates [Line Items]                  
Investments | ₩             ₩ 363,640 ₩ 381,332  
Profit (loss) from investment | ₩     ₩ (17,659)   ₩ 50,073        
Arrow [Member]                  
Investments in and Advances to Affiliates [Line Items]                  
Ownership interest 23.30%         23.30%   23.30%  
Investments $ 1,750         $ 1,750      
Price paid for shares 22                
Price paid for debt 1,728                
Income (loss) from investments   $ (75)              
Artemis Therapeutics, Inc. [Member]                  
Investments in and Advances to Affiliates [Line Items]                  
Ownership interest   3.80%         3.80%    
Carrying value 0 $ 0       0      
Market value $ 10 $ 48       $ 10      
Entity Owned [Member] | Freezone I-SEC Korea Inc. [Member]                  
Investments in and Advances to Affiliates [Line Items]                  
Ownership interest   50.00%         50.00%   50.00%
Artemis Therapeutics, Inc. [Member]                  
Investments in and Advances to Affiliates [Line Items]                  
Common stock purchased | shares   198,311 198,311